Have your own idea? Try our Stock Screener
Chinese (SSE) Biotech Industry Analysis
UpdatedJan 02, 2026
DataAggregated Company Financials
Companies74
- 7D-2.2%
- 3M-9.2%
- 1Y8.3%
- YTDn/a
Over the last 7 days, the Biotech industry has dropped 2.2%, driven by Beijing Wantai Biological Pharmacy Enterprise declining 4.0%. Over the past 12 months, the industry was up 8.3%. As for the next few years, earnings are expected to grow by 41% per annum.
Industry Valuation and Performance
Has the Chinese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 02 Jan 2026 | CN¥915.0b | CN¥106.1b | CN¥3.8b | 47.4x | 242.5x | 8.6x |
| Sun, 30 Nov 2025 | CN¥975.5b | CN¥106.1b | CN¥3.8b | 50.4x | 258.5x | 9.2x |
| Tue, 28 Oct 2025 | CN¥947.2b | CN¥108.2b | CN¥5.0b | 52.8x | 191.1x | 8.8x |
| Thu, 25 Sep 2025 | CN¥971.6b | CN¥107.5b | CN¥5.0b | 51.4x | 192.7x | 9x |
| Sat, 23 Aug 2025 | CN¥1.0t | CN¥108.7b | CN¥6.7b | 42.8x | 149.7x | 9.2x |
| Mon, 21 Jul 2025 | CN¥949.1b | CN¥112.9b | CN¥8.2b | 42.4x | 115.2x | 8.4x |
| Wed, 18 Jun 2025 | CN¥875.5b | CN¥113.0b | CN¥8.3b | 37.9x | 105.6x | 7.7x |
| Fri, 16 May 2025 | CN¥813.8b | CN¥113.4b | CN¥8.4b | 35.1x | 96.8x | 7.2x |
| Sun, 13 Apr 2025 | CN¥845.8b | CN¥135.0b | CN¥11.8b | 31.4x | 71.6x | 6.3x |
| Tue, 11 Mar 2025 | CN¥858.9b | CN¥136.2b | CN¥11.6b | 31.9x | 74.3x | 6.3x |
| Thu, 06 Feb 2025 | CN¥805.9b | CN¥136.0b | CN¥10.8b | 33x | 74.9x | 5.9x |
| Sat, 04 Jan 2025 | CN¥801.5b | CN¥136.0b | CN¥10.8b | 32.5x | 74.5x | 5.9x |
| Mon, 02 Dec 2024 | CN¥921.3b | CN¥141.7b | CN¥11.2b | 36.3x | 82.3x | 6.5x |
| Wed, 30 Oct 2024 | CN¥914.0b | CN¥143.0b | CN¥12.0b | 34.2x | 76.3x | 6.4x |
| Fri, 27 Sep 2024 | CN¥797.6b | CN¥154.1b | CN¥14.5b | 32.6x | 55.2x | 5.2x |
| Sun, 25 Aug 2024 | CN¥765.6b | CN¥161.1b | CN¥17.4b | 27.2x | 44.1x | 4.8x |
| Tue, 23 Jul 2024 | CN¥849.4b | CN¥161.1b | CN¥17.3b | 33.6x | 49.1x | 5.3x |
| Thu, 20 Jun 2024 | CN¥860.7b | CN¥161.1b | CN¥17.3b | 31.8x | 49.8x | 5.3x |
| Sat, 18 May 2024 | CN¥952.3b | CN¥161.1b | CN¥17.3b | 39.1x | 55.2x | 5.9x |
| Mon, 15 Apr 2024 | CN¥937.5b | CN¥161.4b | CN¥20.3b | 37.5x | 46.1x | 5.8x |
| Wed, 13 Mar 2024 | CN¥1.0t | CN¥165.5b | CN¥22.1b | 37x | 46.5x | 6.2x |
| Fri, 09 Feb 2024 | CN¥955.7b | CN¥167.9b | CN¥21.4b | 31.9x | 44.6x | 5.7x |
| Sun, 07 Jan 2024 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 39x | 50.1x | 6.4x |
| Tue, 05 Dec 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 40x | 52.5x | 6.7x |
| Thu, 02 Nov 2023 | CN¥1.1t | CN¥172.1b | CN¥22.7b | 39.4x | 48.1x | 6.4x |
| Sat, 30 Sep 2023 | CN¥1.1t | CN¥170.9b | CN¥25.2b | 42.6x | 41.7x | 6.2x |
| Mon, 28 Aug 2023 | CN¥972.0b | CN¥171.5b | CN¥28.5b | 36.7x | 34.1x | 5.7x |
| Wed, 26 Jul 2023 | CN¥1.1t | CN¥177.4b | CN¥29.9b | 39.6x | 36.3x | 6.1x |
| Fri, 23 Jun 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 37.9x | 36.4x | 6x |
| Sun, 21 May 2023 | CN¥1.2t | CN¥177.7b | CN¥29.6b | 41.5x | 39.2x | 6.5x |
| Tue, 18 Apr 2023 | CN¥1.3t | CN¥187.3b | CN¥36.5b | 43.7x | 35.5x | 6.9x |
| Thu, 16 Mar 2023 | CN¥1.3t | CN¥179.2b | CN¥36.1b | 45x | 34.7x | 7x |
| Sat, 11 Feb 2023 | CN¥1.3t | CN¥179.6b | CN¥37.9b | 43.3x | 34.6x | 7.3x |
| Mon, 09 Jan 2023 | CN¥1.3t | CN¥175.6b | CN¥37.9b | 39.7x | 33.1x | 7.2x |
Price to Earnings Ratio
33.1x
Current Industry PE
- Investors are optimistic on the Chinese Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 243x which is higher than its 3-year average PE of 78.0x.
- The 3-year average PS ratio of 6.7x is lower than the industry's current PS ratio of 8.6x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 54% per year over the last three years,
- Revenues have also declined 15% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | -0.18% | |
| Healthcare | -2.35% | |
| Biotech | -2.19% | |
| Biotech | -2.19% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 688278 Xiamen Amoytop Biotech | CN¥83.68 | 3.4% +CN¥1.1b | 14.5% | PE36.4x | |
| 603087 Gan & Lee Pharmaceuticals | CN¥68.07 | 1.6% +CN¥642.8m | 61.4% | PE43.8x | |
| 688488 Jiangsu Aidea Pharmaceutical Group | CN¥16.33 | 7.9% +CN¥504.9m | 112.6% | PS10.2x | |
| 688443 Chongqing Genrix Biopharmaceutical | CN¥27.24 | 0.6% +CN¥62.3m | 9.4% | PS44.4x | |
| 603387 Getein Biotech | CN¥8.37 | 1.0% +CN¥40.6m | 4.2% | PE20.3x |